Neonatal immune tolerance for hemophilia: can we "tolerate" new paradigms for gene therapy trials?
Monahan
P E
PE
Department of Pediatrics and Gene Therapy Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7220, USA. paul_monahan@med.unc.edu
D000818:Animals; D002986:Clinical Trials as Topic; D005167:Factor VII / Q000008:administration & dosage / Q000276:immunology; D015316:Genetic Therapy; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007108:Immune Tolerance; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D051379:Mice; D012107:Research Design
D005167:Factor VII